APICMO Pharmaceuticals – The Company’s Outlook in the Research, Development and Supply of New Drugs
APICMO are committed to boosting drug efficacy and developing key intermediates for new drugs.
They have been working on research and development of tumor and cancer-targeted drug intermediates.
Florida, United States – November 6, 2018 /MarketersMedia/ —
With more than ten years’ experience in the industry, APICMO Pharmaceuticals has shown some consistent and dedicated efforts in improving the global biochemical landscape. The company has a vertically integrated system of synthetic and customized services for drug research and development. APICMO products and services are committed to boosting drug efficacy and developing key intermediates for new drugs.
As a leading pharmaceutical company, APICMO takes pride in its PHD team that has constantly been hitting the headlines since 2016 when the company first won AIM BY LABORATORY AWARDS. The team has been working on research and development of tumor/cancer-targeted drug intermediates. APICMO has a concentrated focus on new research in the field of oncology and mass production for CDMO and CMO orders. With such specialization, APICMO provides system development and synthetic customization among other services for several pharmaceuticals and drug development firms across the globe.
Some of the products offered by APICMO include, but not limited to; biological and chemically derived pharmaceutical intermediates, APIS and fines. These products range from Pyridines, Heterocycles, Azetidines, Pyrimidines to Chiral compounds. The company’s investment in top-notch research resources has proven to be a vital asset in the development of drug intermediates. It also comes as an added advantage to its advanced undertakings and development projects. With such systems in place; cGMP manufacturing, quality control, and project management become efficient.
With regards to the company’s projects and products; all the manufactured drugs and formulations are tested for quality and safety before their commercial applications. APICMO has an ISO 9001:2008 certification meaning all the business operations strictly complies with the international set of quality standards.
According to a report by BizVibe, a Canadian B2B global networking platform; China’s pharmaceutical market generates $110 billion in revenues and the figure is set to hit $167 billion by 2020. This isn’t a mere speculation, it’s an insight on the global market dynamics as far as development and supply of drugs and other pharmaceutical products is concern. That said, APICMO’s customer base is extensive ranging from international giants to the small bio-pharmaceutical institutions. It has a wide range of both local and overseas customers including drug research and development companies.
As the company seeks to improve the CMO & CDMO processes, it’s also focusing on reducing the cost of delivering their services to clients. In a quest to ascertain the two without compromising on any vital aspect of their services; APICMO has established a reliable network that connects Chinese pharmaceutical firms and manufacturers within the country. Another most recent networking project pulled by the company is a partnership program with research institutes from ICH developed countries and other developing countries such as India. Such approaches help boost the quality of services and provide manufacturers with efficient and cost-effective manufacturing & procurement services.
APICMO is constantly researching and developing an array of products in cutting-edge delivery platforms with pharmaceutical and biotech companies. Besides specializing in key intermediates in developing new drugs, there are certain innovations that are part of the company’s goals in improving the quality of products and services. As part of the innovation, APICMO provides quality studies, process validation, stability, and impurity studies to meet the customer’s IND & NDA requirements. The company also features a strong intellectual property-protection system that ensures clients’ important credentials, trade secrets, trademarks, patents and publicity rights are kept safe within the company.
APICMO has an experienced and highly-productive management team mostly from first-world countries such as Europe, the United States, and Japan. With the efforts of such committed leadership, the company has posted great improvements as far as the utilization of resources and supplying the market is concern.
In recognition of the unrivaled services in the pharmaceutical industry, APICMO has earned three awards. The two most recent being The Best LABORATORY OF THE YEAR, 2017 and the BEST SUPPLIER, 2018. This goes without saying that the company’s services have gained international recognition and it’s actively enjoying a remarkable share of the global market.
Contact Info:
Name: Dr. Zhaosen Zeng
Organization: APICMO Biochemical Technology Co., ltd
Address: Florida
Phone: +1 3204079051
For more information, please visit https://www.apicmo.com/
Source: MarketersMedia
Release ID: 439949
Copyright © 1999-2013 SproutNews.com
